Devices › Recorder, event, implantable cardiac, (with arrhythmia detection)
Device brand name · Implantable cardiac monitor
BIOMONITOR IIIm: medical device reports filed with FDA
435 reports name it, 2020–2026. Manufacturer given most often on reports: Biotronik Se & Kg. Product code MXD.
- 435
- device reports naming the brand
- 0% of all MAUDE reports · about 74 a year
- 66
- reports, 12 months to August 2026
- 108 in the 12 months before
- 39.1%
- classified as malfunction
- 82.8% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
435 medical device reports received by FDA name the brand "BIOMONITOR IIIm" (implantable cardiac monitor); the manufacturer given most often on reports is Biotronik Se & Kg; received from August 2020 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
66 reports arrived in the 12 months to August 2026, down 39% from 108 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (60.9%) and malfunction (39.1%); across all recorder, event, implantable cardiac, (with arrhythmia detection) reports (product code MXD) death is recorded in 0% and malfunction in 82.8%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are migration or expulsion of device (21.8%), failure to interrogate (14.9%) and device sensing problem (11.7%). The patient problems coded most often are wound dehiscence, discomfort and implant pain. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 12,977 reports carrying product code MXD. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Migration or expulsion of device | 95 | 21.8% | 5% |
| Failure to interrogate | 65 | 14.9% | 1.7% |
| Device sensing problem | 51 | 11.7% | 5.3% |
| Ambient noise problem | 23 | 5.3% | 0.6% |
| Failure to sense | 15 | 3.4% | 0.5% |
| Premature elective replacement indicator | 15 | 3.4% | 0.7% |
| Under-sensing | 9 | 2.1% | 7.6% |
| Communication or transmission problemthe device could not communicate or transmit | 8 | 1.8% | 3.2% |
| Device dislodged or dislocated | 8 | 1.8% | 0.3% |
| Battery problema problem with the battery | 7 | 1.6% | 2.7% |
| Interrogation problem | 7 | 1.6% | 0.1% |
| Expulsion | 6 | 1.4% | 0.1% |
| Failure to transmit record | 5 | 1.1% | 0.1% |
| Migrationthe device moved from where it was placed | 5 | 1.1% | 0.6% |
| Premature end-of-life indicator | 5 | 1.1% | 0.1% |
| Failure to analyze signal | 2 | 0.5% | 0% |
| Insufficient device problem information | 2 | 0.5% | 0.2% |
| Breakthe device broke | 1 | 0.2% | 0.1% |
| Data problem | 1 | 0.2% | 5.3% |
| Device damaged by another device | 1 | 0.2% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Wound dehiscencea wound reopened | 74 | 17% |
| Discomfortdiscomfort | 40 | 9.2% |
| Implant pain | 37 | 8.5% |
| Pocket erosion | 34 | 7.8% |
| Twiddlers syndrome | 4 | 0.9% |
| Inflammationinflammation | 3 | 0.7% |
| Hematomaa collection of blood under the skin or in tissue | 2 | 0.5% |
| Hemorrhage/blood loss/bleeding | 2 | 0.5% |
| Skin inflammation/ irritation | 2 | 0.5% |
| Abscessa collection of pus | 1 | 0.2% |
| Arrhythmia | 1 | 0.2% |
| Asystole | 1 | 0.2% |
| Atrial fibrillationan irregular heart rhythm | 1 | 0.2% |
| Bradycardiaslow heart rate | 1 | 0.2% |
| Burning sensationa burning feeling | 1 | 0.2% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | BIOMONITOR IIIm | Product code MXD | All MAUDE reports |
|---|---|---|---|
| Reports | 435 | 12,977 | 26,136,888 |
| Share of that pool | — | 3.4% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 60.9% | 17.2% | 36.2% |
| Classified as malfunction | 39.1% | 82.8% | 62.3% |
| Filed by the manufacturer | 99.8% | 99.6% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MXD
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| LUX-Dx Insertable Cardiac Monitor | 660 | 83 | 0% |
| Biomonitor 2-Af | 231 | 0 | 0.4% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about BIOMONITOR IIIm reports
How many FDA reports name BIOMONITOR IIIm?
435 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 66 in the latest 12 months.
What kinds of events are reported?
injury (60.9%) and malfunction (39.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
migration or expulsion of device (21.8%), failure to interrogate (14.9%), device sensing problem (11.7%), ambient noise problem (5.3%) and failure to sense (3.4%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.8%) and voluntary reports (0.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that BIOMONITOR IIIm was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.